Bictegravir-Lenacapavir Combo Pill Earns FDA Approval in Suppressed HIV
(MedPage Today) -- The FDA approved the combination of bictegravir and lenacapavir (Bixlenvo) for adults with virologically suppressed HIV-1 infection, Gilead Sciences announced Thursday. The once-daily single tablet contains 75 mg of the integrase...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.